Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
adrenergic blocker
adverse drug reaction
alcohol block, subarachnoid
alpha adrenergic blocker
amenorrhea
autonomic dysfunction
benign essential tremor
beta adrenergic blocker
cauda equina
cauda equina, lesion of
cerebral ischemia
dibenzyline
diplopia, monocular
drug induced neurologic disorders
ejaculation
ejaculation, retrograde
erection
fertility
guanethidine
headache
headache, post traumatic
headache, vascular
Horner's syndrome
hyperhidrosis
impotence
labetalol
midodrine
muscle pain
myopathy
myopathy, toxic
myositis
neuropathy, peripheral
orgasm
orthostatic hypotension
orthostatic hypotension, idiopathic
orthostatic hypotension, treatment of
pregnancy, neurologic complications in
priapism
propranolol
ptosis
pupil, abnormality in neurologic disorders
pupil, dilated, unilateral
review article
rhizotomy
rhizotomy, phenol
risk factors
sexual dysfunction in neurologic disease
sexual intercourse
Shy-Drager syndrome
spinal cord, injury of
spinal cord, injury, functional capacity of patient with
spinal cord, injury, sexual dysfunction in
steroid
subarachnoid hemorrhage
subarachnoid hemorrhage, treatment of
sympathectomy
sympatholytic agent
syncope
trauma
treatment of neurologic disorder
tremor
vasopressin
Showing articles 1200 to 1250 of 3506 << Previous Next >>

Extent of Early Ischemic Changes on Computed Tomgraphy (CT) Before Thrombolysis
Stroke 37:973-978, Dzialowski,I.,et al, 2006

What is the Risk of Developing Parkinsonism Following Neuroleptic Use?
Neurol 66:941-943, Noyes,K.,et al, 2006

Imaging-Guided Acute Ischemic Stroke Therapy: From "Time is Brain" to "Physiology is Brain"
AJNR 27:728-735, Gonzalez,R.G., 2006

Practice Parameter: Neuroprotective Strategies and Alternative Therapies for Parkinson Disease (An Evidence-Based Review)
Neurol 66:976-982, Suchowersky,O.,et al, 2006

Statin-Associated Myasthenia Gravis
Medicine 85:82-85, Purvin,V.,et al, 2006

Poststroke C-Reactive Protein Is a Powerful Prognostic Tool Among Candidates for Thrombolysis
Stroke 37:1205-1210, Montaner,J.,et al, 2006

Good Outcomes in Ischemic Stroke Patients treated With Intravenous Thrombolysis Despite Regressing Neurological Symptoms
Stroke 37:1332-1333, Baumann,C.R.,et al, 2006

Mycophenolate Mofetil in Dermatomyositis: Is It Safe?
Neurol 66:1245-1247, Rowin,J.,et al, 2006

Natalizumab: Immune Effects and Implications for Therapy
Ann Neurol 59:731-732, Hauser,S.L. &Weiner, H.L., 2006

Antiplatelets, ACE Inhibitors, and Statins Combination Reduces Stroke Severity and Tissue At Risk
Neurol 66:1153-1158, Kumar,S.,et al, 2006

Is IV Tissue Plasminogen Activator Beneficial in Patients With Hyperdense Artery Sign?
Neurol 66:1171-1174, Qureshi,A.I.,et al, 2006

MATILDE Regimen Followed by Radiotherapy is an Active Strategy Against Primary CNS Lymphomas
Neurol 66:1435-1438, Ferreri,A.J.M.,et al, 2006

Reasons Why Few Patients With Acute Stroke Receive Tissue Plasminogen Activator
Arch Neurol 63:661-664, Bambauer,K.Z.,et al, 2006

Transmission of Lymphocytic Choriomeningitis Virus by Organ Transplantation
NEJM 354:2235-2249, Fischer,S.A.,et al, 2006

Clinicopath Conf, Acute Ischemic Stroke
NEJM 354:2263-2271, Case 16:2006, 2006

Thrombolysis in Patients Older Than 80 Years With Acute Ischaemic Stroke: Canadian Alteplase for Stroke Effectiveness Study
JNNP 77:826-829,812, Sylaja, P.N.,et al, 2006

Safety of Mechanical Thrombectomy and Intravenous Tissue Plasminogen Activator in Acute Ischemic Stroke: Results of the Multi Mechanical Embolus Removal in Cerebral Ischemia (MERCI) Trial, Part I
AJNR 27:1177-1182, W.S. Smith, for the Multi MERCI Investigators, 2006

Ischemic Strokes After Cardiac Catheterization
Arch Neurol 63:817-821, Khatri,P. &Kasner,S.E., 2006

Comparison of Tissue Plasminogen Activator Administration Management Between Telestroke Network Hospitals and Academic Stroke Centers
Stroke 37:1822-1827, Audebert,H.,et al, 2006

Thrombolysis (Tissue Plasminogen Activator) in Stroke: A Medicolegal Quagmire
Stroke 37:1917-1922, Weintraub,M.I., 2006

Door to Thrombolysis: ER Reorganization and Reduced Delays to Acute Stroke Treatment
Neurol 67:334-336, Lindsberg,P.J.,et al, 2006

Intravenous Recombinant Tissue Plasminogen Activator in a Pregnant Woman With Cardioembolic Stroke
Stroke 37:2168-2169, Wiese,K.M.,et al, 2006

Piracetam for Acute Ischemic Stroke
Stroke 37:2191-2192, Ricci,S.,et al, 2006

Neoplastic Meningitis
Neurologist 12:179-187, Chamberlain,M.C., 2006

Emerging Monoclonal Antibody Therapies for Multiple Sclerosis
Neurologist 12:171-178, Cree,B., 2006

Improvement of Postherpetic Neuralgia After Treatment With Intravenous Acyclovir Followed by Oral Valacyclovir
Arch Neurol 63:940-942, Quan,D.,et al, 2006

Axonal Polyneuropathy After Acute Dimethylamine Borane Intoxication
Arch Neurol 63:1009-1012, Kuo,H.-C.,et al, 2006

Diffuse Cerebral Vasoconstriction (Call-Fleming Syndrome) and Stroke Associated with Antidepressants
Neurol 67:159-160, Noskin,O.,et al, 2006

Pesticide Exposure and Risk for Parkinsons Disease
Ann Neurol 60:197-203, Ascherio,A.,et al, 2006

Progressive Multifocal Leukoencephalopathy Revisited: Has the Disease Outgrown Its Name?
Ann Neurol 60:162-173, Koralnik,I.J., 2006

Recurrent Ibuprofen-Induced Aseptic Meningitis: Evidence Against an Antigen-Specific Immune Response
Neurol 67:539-540, Periard,D.,et al, 2006

Interferon beta-1a Treatment in Childhood and Juvenile-Onset Multiple Sclerosis
Neurol 67:511-513, Tenembaum,S.N. &Segura,M.J., 2006

Immune Reconstitution Inflammatory Syndrome in the CNS of HIV Infected Patients
Neurol 67:383-388, Venkataramana,A.,et al, 2006

Characteristics and Antecedents of Progressive Multifocal Leukoencephalopathy in an Insured Population
Neurol 67:884-886, Eng,P.M.,et al, 2006

Intra-Arterial Thrombolysis Is the Treatment of Choice for Basilar Thrombosis: Pro
Stroke 37:2436-2437,2440, Schellinger,P.D. &Hacke,W., 2006

Intra-Arterial Thrombolysis Is the Treatment of Choice for Basilar Thrombosis: Con
Stroke 37:2438-2439,2440, Ford,G.A., 2006

Tandem Internal Carotid Artery/Middle Cerebral Artery Occlusion: An Independent Predictor of Poor Outcome After Systemic Thrombolysis
Stroke 37:2301-2305, Rubiera,M.,et al, 2006

Dystonia
NEJM 355:818-829, Tarsy,D. &Simon,D.K., 2006

High-Dose Atorvastatin After Stroke or Transient Ischemic Attack
NEJM 355:549-559,613, The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators, 2006

Using the Baseline CT Scan to Select Acute Stroke Patients for IV-IA Therapy
AJNR 27:1612-1616, Hill,M.E.,et al, 2006

Oral Fingolimod (FTY720) for Relapsing Multiple Sclerosis
NEJM 355:1124-1140, Kappos,L.,et al, 2006

Urgent Clinical Challenges in Children With Ischemic Stroke
Stroke 37:116-122,3, Kuhle,S.,et al, 2006

Charcot Neuroarthropathy in the Era of HAART
Lancet 367:274, Oh-Park,M.,et al, 2006

Extrathymic Tumors in Patients With Myasthenia Gravis, A 35-Year Retrospective Study
The Neurologist 12:53-55, Wakata,N.,et al, 2006

Classification and Pathogenesis of Cerebral Hemorrhages After Thrombolysis in Ischemic Stroke
Stroke 37:556-561, Trouillas,P. &von Kummer,R., 2006

Factors Associated With In-Hospital Mortality After Administration of Thrombolysis in Acute Ischemic Stroke Patients, An Analysis of the Nationwide Inpatient Sample 1999 to 2002
Stroke 37:440-446, Bateman,B.T.,et al, 2006

Endovascular Recanalization Therapy in Acute Ischemic Stroke
Stroke 37:419-424, Choi,J.H.,et al, 2006

Cerebral Microbleeds on MRI
Neurol 66:165-171, Koennecke,H.-C., 2006

First-Pass Quantitiative CT Perfusion Identifies Thresholds for Salvageable Penumbra in Acute Stroke Patients Treated with Intra-arterial Therapy
AJNR 27:20-25, Schaefer,P.W.,et al, 2006

Perfusion CT Helps Decision Making for Thrombolysis When There is No Clear Time of Onset
JNNP 77:417-419, Hellier,K.D.,et al, 2006



Showing articles 1200 to 1250 of 3506 << Previous Next >>